{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:35:56Z","timestamp":1791423356800,"version":"4.3.3"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,3]]},"abstract":"ABSTRACT<\/jats:title>\n \n We investigated a possible synergistic effect of a macrolide and \u03b2-lactams against\n Streptococcus pneumoniae<\/jats:italic>\n strains with different resistance profiles. Checkerboard and time-kill assays of erythromycin combined with penicillin or cefotaxime essentially showed indifference, suggesting that these antibiotics in combinations in vitro act substantially as individuals in their activity against\n S. pneumoniae<\/jats:italic>\n .\n <\/jats:p>","DOI":"10.1128\/aac.47.3.1151-1153.2003","type":"journal-article","created":{"date-parts":[[2003,2,25]],"date-time":"2003-02-25T18:22:21Z","timestamp":1046197341000},"page":"1151-1153","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Lack of Synergy of Erythromycin Combined with Penicillin or Cefotaxime against\n Streptococcus pneumoniae<\/i>\n In Vitro"],"prefix":"10.1128","volume":"47","author":[{"given":"Eugene","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Medicine, Marshall University School of Medicine, Huntington, West Virginia 25701-3655"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Stanek","sequence":"additional","affiliation":[{"name":"Department of Medicine, Marshall University School of Medicine, Huntington, West Virginia 25701-3655"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice A.","family":"Mufson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Marshall University School of Medicine, Huntington, West Virginia 25701-3655"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"44","year":"1999","unstructured":"Amsden, G. W. 1999. Pneumococcal macrolide resistance\u2014myth or reality? J. Antimicrob. Chemother.44:1-6.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.1973"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/513953"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.2.231"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.5.1166"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.6.973"},{"key":"e_1_3_1_8_2","first-page":"34S","volume":"107","year":"1999","unstructured":"Mufson, M. A., and R. J. Stanek. 1999. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am. J. Med.107:34S-43S.","journal-title":"Am. J. Med."},{"key":"e_1_3_1_9_2","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests 6th ed. Approved standard. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.5.1418"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/30.3.261","volume":"30","year":"1992","unstructured":"Saverino, D., E. A. Debbia, A. Pescue, A. M. Lepore, and G. C. Schito. 1992. Antibacterial profile of flurithromycin, a new macrolide. J. Antimicrob. Chemother.30:261-272.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000441-199510000-00004","volume":"310","year":"1995","unstructured":"Stanek, R. J., and M. A. Mufson. 1995. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am. J. Med. Sci.310:150-155.","journal-title":"Am. J. Med. Sci."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.15.1837"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.3.1151-1153.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.3.1151-1153.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:04:35Z","timestamp":1645466675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.3.1151-1153.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["10.1128\/AAC.47.3.1151-1153.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.3.1151-1153.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"2002-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}